Last reviewed · How we verify

NCT05515913: ASD

Nutritional Status and ASD Severity of Autistic Spectrum Disorder Children in Addis Ababa, Ethiopia; Case Control Study

Completed Last updated 25 August 2022
What this trial tests

trial testing Nutritional status in Autistic Spectrum Disorder in 52 participants. Completed in 8 February 2022.

Timeline
14 August 2021
Primary endpoint
23 November 2021
8 February 2022

Quick facts

Lead sponsorAddis Ababa University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date14 August 2021
Primary completion23 November 2021
Estimated completion8 February 2022
Sites1 location across Ethiopia

Drugs / interventions tested

Conditions studied

Sponsor

Addis Ababa University

Who can join

Adults 4 to 18, any sex, with Autistic Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study conducts a case control analysis of the nutritional status and intake of autistic spectrum disorder diagnosed children as compared to typically developing children in Addis Ababa, Ethiopia. It included analysis of anthropometric measurements, three days food diary food intake, urinary iodine analysis, childhood autism rating scale diagnosis, food frequency and eating behavior questioner and proximate analysis of one day major meals of selected subjects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Nutritional status

Trials testing the same drug.

Other recruiting trials for Autistic Spectrum Disorder

Currently open trials in the same condition.

Other Addis Ababa University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05515913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing